These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 29873321

  • 1. Natural Diterpenoid Isoferritin A (IsoA) Inhibits Glioma Cell Growth and Metastasis via Regulating of TGFβ-Induced EMT Signal Pathway.
    Shen B, Sun D.
    Med Sci Monit; 2018 Jun 06; 24():3815-3823. PubMed ID: 29873321
    [Abstract] [Full Text] [Related]

  • 2. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y, Cheng YX, Wu ZQ.
    J Exp Clin Cancer Res; 2019 Mar 21; 38(1):134. PubMed ID: 30898152
    [Abstract] [Full Text] [Related]

  • 3. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X, Zheng K, Li C, Zhao Y, Li H, Liu X, Long Y, Yao J.
    Oncol Rep; 2017 May 21; 37(5):2847-2856. PubMed ID: 28339056
    [Abstract] [Full Text] [Related]

  • 4. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition.
    Wang Z, Liu Z, Yu G, Nie X, Jia W, Liu RE, Xu R.
    Neurochem Res; 2018 Mar 21; 43(3):760-774. PubMed ID: 29423667
    [Abstract] [Full Text] [Related]

  • 5. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas.
    Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, Zhang Z, Zhang S, Qi Y, Sun X, Xue H, Guo X, Zhao R, Li G.
    Mol Oncol; 2020 Feb 21; 14(2):407-425. PubMed ID: 31856384
    [Abstract] [Full Text] [Related]

  • 6. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J, Li Q, Lin L, Wang R, Chen L, Du W, Jiang C, Li R.
    BMC Neurol; 2018 Aug 31; 18(1):133. PubMed ID: 30170559
    [Abstract] [Full Text] [Related]

  • 7. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L, Shen D, Li X, Shan X, Wang X, Yan Q, Liu J.
    Oncotarget; 2016 Jan 12; 7(2):1619-32. PubMed ID: 26636541
    [Abstract] [Full Text] [Related]

  • 8. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
    Bao Z, Chen L, Guo S.
    J Cell Biochem; 2019 Jun 12; 120(6):10205-10214. PubMed ID: 30592329
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.
    BMC Cancer; 2015 Mar 05; 15():97. PubMed ID: 25884904
    [Abstract] [Full Text] [Related]

  • 10. Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
    Chen J, Huang X, Li N, Liu B, Ma Z, Ling J, Yang W, Li T.
    Mol Med Rep; 2020 Dec 05; 22(6):5113-5124. PubMed ID: 33174044
    [Abstract] [Full Text] [Related]

  • 11. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D, Xu X, Li J, Chen C, Chen W, Wang F, Xie Y, Li F.
    Int J Oncol; 2018 Nov 05; 53(5):2067-2080. PubMed ID: 30106127
    [Abstract] [Full Text] [Related]

  • 12. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
    Liang C, Yang Y, Guan J, Lv T, Qu S, Fu Q, Zhao H.
    Pathol Res Pract; 2018 Sep 05; 214(9):1474-1481. PubMed ID: 30107990
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G, Lu G, Yu J, Zhao Y, Wang C, Zhang H, Xia Q.
    Eur J Pharmacol; 2019 Oct 05; 860():172551. PubMed ID: 31323225
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
    Zhang G, Feng W, Wu J.
    Biomed Pharmacother; 2020 May 05; 125():109768. PubMed ID: 32106387
    [Abstract] [Full Text] [Related]

  • 15. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
    Bian E, Chen X, Xu Y, Ji X, Cheng M, Wang H, Fang Z, Zhao B.
    J Exp Clin Cancer Res; 2019 Aug 20; 38(1):366. PubMed ID: 31429770
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H, Guo L, Xi J, Wang D.
    Tumour Biol; 2017 Jun 20; 39(6):1010428317713389. PubMed ID: 28651497
    [Abstract] [Full Text] [Related]

  • 17. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
    Jeon MJ, Kim WG, Lim S, Choi HJ, Sim S, Kim TY, Shong YK, Kim WB.
    Mol Cell Endocrinol; 2016 Jan 05; 419():113-23. PubMed ID: 26463583
    [Abstract] [Full Text] [Related]

  • 18. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.
    Carcinogenesis; 2013 Apr 05; 34(4):874-84. PubMed ID: 23275155
    [Abstract] [Full Text] [Related]

  • 19. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F, Zhao Z, Cai X, Heng X, Ma X.
    Cancer Med; 2023 Mar 05; 12(5):5889-5907. PubMed ID: 36284444
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
    Fang Y, Chen Y, Yu L, Zheng C, Qi Y, Li Z, Yang Z, Zhang Y, Shi T, Luo J, Liu M.
    J Natl Cancer Inst; 2013 Jan 02; 105(1):47-58. PubMed ID: 23178439
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.